Our Mission
The Sturge-Weber Foundation (The SWF) global mission is to improve the quality of life and care for people with Sturge-Weber syndrome and associated Port-Wine Birthmark conditions through tenacious collaboration with clinical partners and pioneers, education, advocacy, research and friendly support. Learn more and get involved.
What's New In Research
Multicenter Research Data of Epilepsy Management in Patients With Sturge-Weber Syndrome
Sturge Weber Twitter
Our Sponsors
Matthew Shirley, PhD, Senior Expert Data Scientist, Novartis Institutes of Biomedical Research, Cambridge, MA will transition into the Chief Scientific Officer role for the SWF.
Thursday, April 15th, Qlaris announced its first patient enrollment in a 1/2 clinical program of QLS-101. QLS-101, is an investigational therapy designed to lower intraocular pressure (IOP) by reducing episcleral venous pressure (EVP) in individuals with glaucoma.
